Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)

NCT00390195 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: RAD001 (everolimus)
DRUG: RAD001 (everolimus)

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]